Business to Business Opportunities

Horizon Diagnostics supports the development of next generation targeted sequencing assays by providing bulk volumes of its validated, genetically defined, reference standards directly to developers for assay development and validation through to incorporation within their distributed kits or in-house services. Horizon Diagnostic’s patented gene editing technology enables it to supply developers with an evergreen source of reference material that is genetically defined and validated for the frequency of the mutation. This enables Horizon Diagnostic’s to facilitate the development of novel molecular assays from beginning to end.

Horizon's genetically defined reference standards are an evergreen source of reference material that can provide comparability and standardization across the three phases of the development; and for the lifetime of the assay as a distributed product or service.

To discuss the opportunity to incorporate Horizon’s genetically defined reference standards into your marketed assay please Contact Us or dial UK 01223 655583; US +16174184190

• To view our up-to-date catalogue of reference standards: Click Here
• To discuss generating your own custom engineered cell line references: Contact Us
• To learn more about our patented gene-editing platform: Click Here
• For a collection of application notes: Click Here
  
• For our FAQ for Assay Developers: Click Here